← Leaderboards
Jian Cao
State University New York Stony Brook
$2,351,098
Attributed
$2,987,988
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $392K · FY2006–15$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,987,988 · 2
By mechanism
R01$2,987,988 · 2
Top collaborators
- Nicole S. Sampson4 shared
Most similar at State University New York Stony Brook
Same institution · by research overlap
- Nicole S. Sampson$14,394,601
- Wen-Tien Chen$8,797,075
- Charles R Iden$6,529,286
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsPlayEpithelial To Mesenchymal TransitionPeptidesPropertyTumor Cell InvasionCell SurfaceEpithelialIn VivoNeoplasm MetastasisPreventBiologicalBaseSpecificityCancer CellCellsCancer ModelDrug DiscoveryBehaviorIn VitroMalignant NeoplasmsCancer TherapyBlood VesselsBlood
Grant awards (13)
Integrating Anti-invasive and Anti-growth Therapies Targeting Cancer Metastasis$325,775
R01 · FY2015 · CA · contact PI
Integrating Anti-invasive and Anti-growth Therapies Targeting Cancer Metastasis$316,002
R01 · FY2014 · CA · contact PI
Integrating Anti-invasive and Anti-growth Therapies Targeting Cancer Metastasis$306,229
R01 · FY2013 · CA · contact PI
Integrating Anti-invasive and Anti-growth Therapies Targeting Cancer Metastasis$325,775
R01 · FY2012 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$267,147
R01 · FY2010 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$123,480
R01 · FY2010 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$267,147
R01 · FY2009 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$46,934
R01 · FY2009 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$267,147
R01 · FY2008 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$124,860
R01 · FY2008 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$267,147
R01 · FY2007 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$75,885
R01 · FY2007 · CA · contact PI
Targeting the PEX Domain of MT1-MMP: Novel Cancer Therapy$274,460
R01 · FY2006 · CA · contact PI